The query conflates two distinct biological entities:
PelA: A well-characterized enzyme in Pseudomonas aeruginosa involved in biofilm formation via modification of the Pel polysaccharide .
Pelota homolog: A conserved eukaryotic/archaeal protein involved in mRNA surveillance and ribosome rescue (not mentioned in any provided sources).
No genomic or biochemical data in the search results associate Cenarchaeum symbiosum with a "pelA" gene or a pelota homolog.
The C. symbiosum genome (assembled from sponge symbionts) reveals metabolic pathways but no pelota-related genes :
No "pelA" homologs or pelota-related domains were identified in its genome.
The search results extensively describe PelA’s role in P. aeruginosa biofilm formation. Key findings include:
| Mutation Type | Phenotypic Outcome | Citation |
|---|---|---|
| Active-site residues | Loss of deacetylase activity; abolished biofilm | |
| TPR-binding deletions | Disrupted PelA-PelB interaction; no Pel secretion |
The discrepancy arises from:
Taxonomic misassignment: C. symbiosum (archaeon) lacks documented pelota homologs or PelA-like systems.
Terminological overlap: "PelA" refers solely to Pseudomonas biofilm proteins, not archaeal proteins.
To address the query’s intent, consider:
Re-examining the organism (e.g., C. symbiosum vs. P. aeruginosa).
Exploring pelota homologs in archaea using specialized databases (e.g., UniProt, InterPro).
Validating gene annotations in C. symbiosum’s genome for mRNA surveillance systems.
KEGG: csy:CENSYa_1016
Cenarchaeum symbiosum is a marine archaeon belonging to the Thaumarchaeota phylum, closely related to Nitrosopumilus as indicated in taxonomic studies . It was first isolated as a symbiont of marine sponges and represents one of the first thoroughly studied mesophilic archaea. The pelota homolog (pelA) is particularly significant in understanding translation quality control mechanisms in archaea and potentially provides evolutionary insights into similar mechanisms in eukaryotes.
The protein is preserved in a Tris-based buffer with 50% glycerol and requires storage at -20°C, or -80°C for extended preservation . This recombinant protein is produced specifically for research applications and is not intended for human, veterinary, or therapeutic applications .
Based on homology with pelota proteins in other organisms, pelA likely plays a critical role in mRNA surveillance and ribosome recycling pathways. These pathways are essential for maintaining translation fidelity by eliminating defective mRNAs and rescuing stalled ribosomes. Research approaches to investigate this function include:
In vitro translation assays with purified components
Ribosome binding studies using gradient centrifugation
mRNA decay analysis in reconstituted systems
Protein-protein interaction studies with predicted pathway components
To investigate pelA's role in translation quality control, researchers should consider the following methodological approaches:
Reconstituted in vitro translation systems incorporating purified recombinant pelA
Site-directed mutagenesis of conserved residues to identify functional domains
Cryo-EM structural studies of pelA-ribosome complexes
Comparative analysis with eukaryotic pelota proteins using chimeric constructs
These approaches should be designed to test specific hypotheses about pelA's molecular function, particularly focusing on its interaction with mRNA surveillance machinery unique to archaeal systems.
While the search results don't provide direct comparative data, this research question requires methodological approaches including:
Sequence alignment and phylogenetic analysis
Structural superimposition of solved structures
Functional complementation studies in heterologous systems
Domain swapping experiments to identify functionally conserved regions
These methodologies allow researchers to address fundamental questions about the evolution of translation quality control mechanisms across domains of life.
To identify previously unknown protein-protein interactions involving pelA, researchers should consider:
Affinity purification coupled with mass spectrometry (AP-MS)
Yeast two-hybrid screening adapted for archaeal proteins
Protein microarray analysis
Cross-linking mass spectrometry (XL-MS) to capture transient interactions
Each method offers distinct advantages for capturing different types of interactions, and researchers should consider employing multiple complementary approaches for comprehensive interaction mapping.
The optimal expression system for recombinant pelA production depends on research objectives:
| Expression System | Advantages | Disadvantages | Optimal Application |
|---|---|---|---|
| E. coli | High yield, cost-effective, rapid | Potential improper folding of archaeal proteins | Initial structural studies, antibody production |
| Archaeal hosts (e.g., Sulfolobus) | Native-like folding, post-translational modifications | Lower yield, technical complexity | Functional studies requiring authentic structure |
| Cell-free systems | Rapid, avoids toxicity issues | Expensive, lower scale | Preliminary functional assays, protein engineering |
| Yeast expression | Eukaryotic processing, secretion possible | Glycosylation patterns differ | Comparative studies with eukaryotic homologs |
For initial purification, researchers should verify that their recombinant pelA maintains proper folding and activity before proceeding to functional studies.
Based on the product information, pelA is supplied in a Tris-based buffer with 50% glycerol . For functional studies, researchers should consider:
Maintaining protein in Tris or HEPES buffers (pH 7.5-8.0) to mimic physiological conditions
Including stabilizing agents such as glycerol (10-20%) to prevent aggregation
Adding reducing agents (DTT or β-mercaptoethanol) to maintain cysteine residues
Incorporating divalent cations (Mg²⁺) that might be required for functional activity
Storage at -20°C is appropriate for short-term use, while -80°C is recommended for long-term storage to maintain protein integrity .
Functional validation of recombinant pelA should include:
Ribosome binding assays to confirm interaction with translation machinery
ATPase activity measurements if pelA exhibits predicted enzymatic function
mRNA substrate binding studies using fluorescence anisotropy or electrophoretic mobility shift assays
In vitro reconstitution of translation quality control using defined components
These assays provide complementary information about different aspects of pelA function and should be selected based on specific research questions.
Rigorous experimental design for pelA studies should include:
Negative controls:
Buffer-only controls without pelA
Inactive mutant versions of pelA (with mutations in predicted functional domains)
Heterologous proteins of similar size and charge properties
Positive controls:
Well-characterized pelota homologs from model organisms
Native (non-recombinant) pelA when available
Parallel experiments with established components of the quality control machinery
Validation controls:
Multiple independent protein preparations
Concentration gradients to establish dose-dependence
Time-course experiments to capture kinetic parameters
C. symbiosum is a mesophilic archaeon, suggesting its proteins function optimally at moderate temperatures. To investigate temperature-dependent activity:
Perform activity assays across a temperature range (4-60°C)
Monitor protein stability using circular dichroism at different temperatures
Compare activity profiles with pelota homologs from thermophilic and psychrophilic archaea
Correlate temperature optima with the ecological niche of C. symbiosum
Data should be presented as temperature-activity profiles with appropriate statistical analysis to identify significant temperature effects.
When facing contradictory results regarding pelA function, researchers should:
Systematically compare experimental conditions between studies
Evaluate differences in protein preparation methods that might affect activity
Consider species-specific differences if comparing pelA homologs
Perform side-by-side experiments with standardized protocols
A comprehensive meta-analysis approach using the following framework helps resolve contradictions:
| Parameter | Study A Findings | Study B Findings | Reconciliation Approach |
|---|---|---|---|
| Buffer composition | Activity in Tris | Inactivity in Phosphate | Compare activity in both buffers using identical protein preparations |
| Temperature dependence | Optimal at 25°C | Optimal at 37°C | Construct full temperature-activity curves under otherwise identical conditions |
| Substrate specificity | Binds mRNA with stalled ribosomes | Binds free mRNA | Test binding under both conditions with controlled ribosome concentrations |
| Interaction partners | Interacts with factor X | No interaction with factor X | Verify purity and activity of factor X, use multiple interaction detection methods |
When analyzing functional data for recombinant pelA:
Use appropriate replication (minimum n=3) for all experimental conditions
Apply parametric tests (t-test, ANOVA) for normally distributed data
Consider non-parametric alternatives when assumptions of normality are violated
Report effect sizes alongside p-values to indicate biological significance
Use multiple comparison corrections (e.g., Bonferroni) when testing numerous hypotheses
Experimental data should be presented with clear statistical annotations and appropriate graphical representations that accurately depict both central tendency and variability.
Archaeal proteins often present solubility challenges when expressed in heterologous systems. Methodological approaches include:
Optimize expression conditions:
Reduce induction temperature (16-20°C)
Use weaker promoters to slow expression rate
Co-express molecular chaperones
Modify protein constructs:
Create truncated versions focusing on functional domains
Remove hydrophobic regions that may cause aggregation
Add solubility tags (MBP, SUMO, TRX)
Adjust purification protocols:
Include stabilizing agents (glycerol, low concentrations of denaturants)
Use higher salt concentrations in buffers
Incorporate detergents for partially hydrophobic proteins
To maintain pelA activity throughout purification and storage:
Minimize freeze-thaw cycles by aliquoting protein after initial purification
Store in appropriate conditions (-20°C for short-term, -80°C for long-term storage)
Include stabilizing agents in storage buffer (50% glycerol as indicated in product specifications)
Add protease inhibitors to prevent degradation
Consider protein-specific stabilizing factors identified through thermal shift assays